Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
—
across known amounts
Stages
Pre-Seed, Seed, Series A, Series B, Series C, Early stage, Growth Stage, Late stage, Initial Revenues, R&D, Revenue Growth
About
SBI JI Innovation Fund was formed in early 2017 as a partnership between SBI Holdings, a Japanese financial services group, and Vertex Israel, a leading Israeli venture capital firm. The fund focuses on investing in Israeli or Israel-related venture-backed biopharma and high-tech companies across different developmental stages. It also aims to expand its interests to new sectors and territories, collaborating in Israel and surrounding countries.
Portfolio
No portfolio companies in this dataset yet.
Q&A
- What is the primary focus of SBI JI Innovation Fund?
- SBI JI Innovation Fund focuses on investing in Israeli or Israel-related venture-backed biopharma and high-tech companies across different developmental stages.
- When was SBI JI Innovation Fund established?
- SBI JI Innovation Fund was formed in early 2017 as a partnership between SBI Holdings of Japan and Vertex Israel.
- What are the preferred sectors for investment by SBI JI Innovation Fund?
- SBI JI Innovation Fund prefers sectors such as Healthcare, Immunology, Biopharmaceutical, Enterprise, Cybersecurity, Fintech, and Biotechnology.
- What investment stages does SBI JI Innovation Fund target?
- SBI JI Innovation Fund targets a wide range of investment stages, including Pre-Seed, Seed, Series A, Series B, Series C, Early stage, Growth Stage, and Late stage.
- What is the typical check size for SBI JI Innovation Fund investments?
- SBI JI Innovation Fund typically invests between $4.7 million and $80 million per company.
- Who are some of the key partners at SBI JI Innovation Fund?
- Key partners at SBI JI Innovation Fund include Masa Tanaka (President), Ryo Nakashima (Managing Director), David Heller (General Partner), and Ran Gartenberg (General Partner & CFO).
- What is SBI JI Innovation Fund's investment thesis?
- SBI JI Innovation Fund cherry-picks Israeli (or Israel-related) venture-backed biopharma and high-tech companies with state-of-the-art scientific foundations, strong IP protection, existing investments from world-class investors, and experienced management.